Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PASGthis companyPassage Bio, Inc.	$3.80	-0.82×	2×	0×	-0.34×	101.7%	0.0%	0.0%	0.0%	-242.7%	-100.9%	-84.2%	1.28×	0.5×	0×	2.07×	0.0%	1	-43.91	2	C
ALLRAllarity Therapeutics, Inc.	$0.98	-1.38×	1.58×	48.53×	-0.2×	20.0%	100.0%	-3939.1%	-3509.7%	-114.3%	-112.3%	-95.5%	0.14×	1.2×	-68.14×	2.13×	0.0%	1	-6.62	1	C-
CINGCingulate Inc.	$4.31	-1.05×	9.4×	0×	-1.1×	-99.0%	0.0%	0.0%	0.0%	-894.8%	-176.5%	-73.8%	3.5×	0.11×	-21.57×	1.16×	0.0%	2	-3.41	2	C
LSTALisata Therapeutics, Inc.	$1.06	-0.97×	1.09×	95.05×	-0.01×	89.2%	14.1%	-10711.2%	-9756.5%	-111.7%	-117.3%	-98.9%	0×	0.92×	0×	5.76×	0.0%	1	-74.76	2	C
MTVAMetaVia Inc.	$1.45	-1.15×	2.79×	0×	-0.37×	340.1%	0.0%	0.0%	0.0%	-243.3%	-21.6%	-105.6%	0.04×	0.78×	0×	1.93×	0.0%	0	-18.95	3	B
XCURExicure, Inc.	$0.91	-6.86×	8.69×	0×	-5.97×	-65.3%	0.0%	0.0%	0.0%	-126.0%	-86.8%	-25.1%	0.04×	0.7×	-10,117×	1.19×	0.0%	1	-27.84	1	C-
Peer median	—	-1.15×	2.79×	0×	-0.37×	20.0%	0.0%	0.0%	0.0%	-126.0%	-112.3%	-95.5%	0.04×	0.78×	-21.57×	1.93×	0.0%	1	-18.95	2	—